Entera Bio Ltd.

8 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Aug 2029

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Mar 24, 2027
The maintenance fee for Methods and compositions for oral administration (US 10,420,721) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
1 fee due May 17, 2027
The maintenance fee for Methods and compositions for oral administration of insulin (US 9,186,412) comes due May 17, 2027. Unpaid by Nov 17, 2027, it lapses early.
1 fee due Sep 10, 2027
The maintenance fee for Formulations for Oral Administration of Active Agents (US 10,583,177) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 9,186,412	Methods and compositions for oral administration of insulin In force Term ends Aug 11, 2029 · From the USPTO record	In force	Term ends Aug 11, 2029	From the USPTO record
US 10,010,503	Methods and compositions for oral administration In force Ends no later than Aug 11, 2029 · From the USPTO record	In force	Ends no later than Aug 11, 2029	From the USPTO record
US 10,420,721	Methods and compositions for oral administration In force Ends no later than Aug 11, 2029 · From the USPTO record	In force	Ends no later than Aug 11, 2029	From the USPTO record
US 11,246,827	Methods and compositions for oral administration In force Ends no later than Aug 11, 2029 · From the USPTO record	In force	Ends no later than Aug 11, 2029	From the USPTO record
US 12,311,051	Methods and compositions for oral administration In force Term ends Oct 19, 2030 · From the USPTO record	In force	Term ends Oct 19, 2030	From the USPTO record
US 10,583,177	Formulations for Oral Administration of Active Agents In force Term ends Feb 9, 2036 · High confidence	In force	Term ends Feb 9, 2036	High confidence
US 12,076,373	Formulations for Oral Administration of Active Agents In force Term ends Feb 9, 2036 · Low confidence	In force	Term ends Feb 9, 2036	Low confidence
US 12,239,691	Formulations for Oral Administration of Active Agents In force Term ends Aug 17, 2037 · High confidence	In force	Term ends Aug 17, 2037	High confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 2 abandoned · 1 no status recorded

List them